PDL BioPharma, Inc. R&D Expenses

R&D Expenses of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including R&D Expenses growth rates and interactive chart. Research and development (R&D) expenses are associated with the research and development of a company's goods or services. A company generally incurs R&D expenses in the process of finding and creating new products or services. It is an operating expense and can be deducted from a company's income taxes.

Highlights and Quick Summary

  • R&D Expenses for the quarter ending June 29, 2020 was $1.47 Million (a -21.07% decrease compared to previous quarter)
  • Year-over-year quarterly R&D Expenses decreased by -66.01%
  • Annual R&D Expenses for 2019 was $7.31 Million (a 147.31% increase from previous year)
  • Annual R&D Expenses for 2018 was $2.96 Million (a -59.96% decrease from previous year)
  • Annual R&D Expenses for 2017 was $7.38 Million (a 93.22% increase from previous year)
  • Twelve month R&D Expenses ending June 29, 2020 was $8.83 Million (a 7.01% increase compared to previous quarter)
  • Twelve month trailing R&D Expenses increased by 27.79% year-over-year
Trailing R&D Expenses for the last four month:
29 Jun '20 30 Mar '20 30 Dec '19 29 Sep '19
$8.83 Million $8.25 Million $7.31 Million $6.91 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical R&D Expenses of PDL BioPharma, Inc.

Most recent R&D Expensesof PDLI including historical data for past 10 years.

Interactive Chart of R&D Expenses of PDL BioPharma, Inc.

PDL BioPharma, Inc. R&D Expenses for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 $1.47 $1.86
2019 $1.2 $4.31 $0.89 $0.91 $7.31
2018 $0.81 $0.67 $0.68 $0.79 $2.96
2017 $0.73 $0.61 $4.28 $1.77 $7.38
2016 $1.89 $1.93 $3.82

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.